Oncology Institute (TOIIW) Accumulated Expenses (2019 - 2026)

Oncology Institute (TOIIW) has 8 years of Accumulated Expenses data on file, last reported at $24.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 3.68% year-over-year to $24.3 million; the trailing twelve-month figure through Mar 2026 stood at $24.3 million (up 3.68% YoY), and the FY2025 full-year result was $20.6 million, down 2.15% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $24.3 million, up from $20.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $24.3 million in Q1 2026 and bottomed at $12.2 million in Q1 2023.
• The 5-year median for Accumulated Expenses is $16.1 million (2022), against an average of $17.5 million.
• The widest annual swing landed in 2022, when Accumulated Expenses surged 18045.0%; it then fell 21.21% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $14.6 million in 2022, then declined by 4.1% to $14.0 million in 2023, then soared by 50.71% to $21.1 million in 2024, then decreased by 2.15% to $20.6 million in 2025, then climbed by 17.72% to $24.3 million in 2026.
• The last three Accumulated Expenses figures came in at $24.3 million (Q1 2026), $20.6 million (Q4 2025), and $22.8 million (Q3 2025), per Business Quant data.

Peer Comparison